Status:
ACTIVE_NOT_RECRUITING
Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 Questionnaires
Lead Sponsor:
Institut Curie
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to validate the EORTC PATSAT-C33 and EORTC OUT-PATSAT7 questionnaires scale structure in a large international field study.
Detailed Description
Patient satisfaction is now recognized as an important indicator of care quality. Measures of patient satisfaction with care can facilitate monitoring initiatives for care improvement over time. The E...
Eligibility Criteria
Inclusion
- Patients regardless of cancer site or stage of disease (i.e. local, loco-regional, metastatic, in remission) will be invited to participate if they meet the following criteria:
- Diagnosis of cancer confirmed histologically.
- Patients are 18 years or older (to be adapted for compliance with each country regulation).
- Patients are willing to express their non-opposition to participate in the study.
- Patients are able to read and understand the language of questionnaires.
- Patients have the cognitive ability to complete the questionnaires.
- Patients have had a sufficient experience of the cancer treatment setting :
- a. For outpatients consulting in a chemotherapy day clinic/consultation for oral treatment, ambulatory radiotherapy or consultation for follow-up surveillance to check for signs of recurrence : i) between 3 to 6 cycles of chemotherapy or at least 2 cycles of other cancer treatment (e.g., biological oral therapy) or ii) between 2 to 6 weeks of radiotherapy or iii) within the 3rd to 24th month post-cancer treatment. b. For inpatients consulting on an oncology or a surgery ward at least 3 days of hospital stay
Exclusion
- Patients will be excluded if they are :
- Participating in another patient-reported outcome investigation that may interfere with this study.
- Experiencing any psychiatric condition or major cognitive impairment that may hamper completion of self-reported questionnaires.
Key Trial Info
Start Date :
November 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2025
Estimated Enrollment :
690 Patients enrolled
Trial Details
Trial ID
NCT05989191
Start Date
November 15 2019
End Date
March 30 2025
Last Update
February 7 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie
Paris, France, 75005
2
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France, 54519